Dowe need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2)

被引：24
|
作者：
Maisel, Alan S. [1 ,2 ]
Di Somma, Salvatore [3 ]
机构：
[1] San Diego Vet Affairs Med Ctr, Div Cardiol, Vamc 3350 La Jolla Village Dr, San Diego, CA 92161 USA
[2] Univ Calif San Diego, Vamc 3350 La Jolla Village Dr, San Diego, CA 92161 USA
[3] Sapienza Univ, Sch Med & Psychol, Emergency Med St Andrea Hosp, Dept Med Surg Sci & Translat Med, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷 / 30期
关键词：
NATRIURETIC PEPTIDE LEVELS; FAMILY-MEMBER ST2; EMERGENCY DIAGNOSIS; PROGNOSTIC VALUE; TROPONIN; THERAPY; PROCALCITONIN; GALECTIN-3; MORTALITY; PROTEIN;
D O I：
10.1093/eurheartj/ehw462
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2325 / 2332A
页数：9
相关论文
共 50 条
  • [41] Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T
    Dispenzieri, Angela
    Gertz, Morie A.
    Saenger, Amy
    Kumar, Shaji K.
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Leung, Nelson
    Zeldenrust, Steven
    Hayman, Suzanne R.
    Kapoor, Prashant
    Grogan, Martha
    Hwa, Lisa
    Russell, Stephen J.
    Go, Ronald S.
    Rajkumar, S. Vincent
    Kyle, Robert A.
    Jaffe, Allan
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 524 - 528
  • [42] The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients
    Traxler, Denise
    Zimmermann, Matthias
    Simader, Elisabeth
    Veraar, Cecilia M.
    Moser, Bernhard
    Mueller, Thomas
    Mildner, Michael
    Dannenberg, Varius
    Lainscak, Mitja
    Jug, Borut
    Ankersmit, Hendrik J.
    CLINICA CHIMICA ACTA, 2020, 510 : 507 - 514
  • [43] Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure A Meta-Analysis
    Aimo, Alberto
    Vergaro, Giuseppe
    Passino, Claudio
    Ripoli, Andrea
    Ky, Bonnie
    Miller, Wayne L.
    Bayes-Genis, Antoni
    Anand, Inder
    Januzzi, James L.
    Emdin, Michele
    JACC-HEART FAILURE, 2017, 5 (04) : 280 - 286
  • [44] Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation
    Galeone, Antonella
    Salem, Joe-Elie
    Lebreton, Guillaume
    Coutance, Guillaume
    Nguyen, Lee
    Hulot, Jean Sebastien
    Atassi, Fabrice
    Bega, Marco
    Leprince, Pascal
    Varnous, Shaida
    CLINICAL TRANSPLANTATION, 2022, 36 (05)
  • [45] sST2 for Outcome Prediction in Acute Heart Failure Which Is the Best Cutoff?
    Aimo, Alberto
    Maisel, Alan S.
    Castiglione, Vincenzo
    Emdin, Michele
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) : 478 - 479
  • [46] Correlation between soluble suppression of tumorigenicity 2 (sST2) and endoscopic activity in patients with moderate to severe ulcerative colitis under golimumab treatment: results of the EVOLUTION study
    Magro, F.
    Lopes, S.
    Silva, M.
    Coelho, R.
    Portela, F.
    Branquinho, D.
    Correia, L.
    Fernandes, S.
    Cravo, M.
    Caldeira, P.
    Sousa, H.
    Patita, M.
    Lago, P.
    Ramos, J.
    Afonso, J.
    Redondo, I.
    Machado, P.
    Philip, G.
    Lopes, J.
    Carneiro, F.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S363 - S363
  • [47] sSt2 Level at Decompensated Chronic Heart Failure in Patients with Dilated Cardiomyopathy
    Gulomov, Khumoyun A.
    Abdullaev, Timur A.
    Tsoi, Igor A.
    Ziyaeva, Adolat, V
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (02) : 222 - 226
  • [48] SOLUBLE SUPPRESSION OF TUMORIGENICITY 2 (SST2) AND CARDIOVASCULAR OUTCOMES IN PERSONS WITH TYPE 2 DIABETES MELLITUS RANDOMIZED TO DAPAGLIFLOZIN OR PLACEBO: ANALYSES FROM THE DECLARE-TIMI 58 TRIAL
    Haller, Paul
    Wiviott, Stephen
    Jarolim, Petr
    Goodrich, Erica L.
    Bhatt, Deepak L.
    Gause-Nilsson, Ingrid
    Leiter, Lawrence A.
    McGuire, Darren K.
    Raz, Itamar
    Wilding, John
    Sabatine, Marc Steven
    Morrow, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 378 - 378
  • [49] Serum-soluble suppression of tumourigenicity-2 as a biomarker in children with congestive heart failure
    Amer, Eslam
    El Amrousy, Doaa
    Hazaa, Sahar
    Zoair, Amr
    CARDIOLOGY IN THE YOUNG, 2023, 33 (12) : 2481 - 2486
  • [50] Serial sST2 measurement to evaluate volume status in acute decompensated heart failure
    de Roeck, Frederic
    Mortelmans, P.
    Hansen, D.
    Houbrechts, M.
    Dendale, P.
    ACTA CARDIOLOGICA, 2016, 71 (01) : 94 - 94
12345